Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Epidemiology, Clinical Features, Diagnosis and Treatment of Cerebral Mucormycosis in Diabetic Patients: A Systematic Review of Case Reports and Case Series Publisher Pubmed



Chegini Z1 ; Didehdar M2 ; Khoshbayan A3 ; Rajaeih S4 ; Salehi M5 ; Shariati A6
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Microbiology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
  2. 2. Department of Medical Parasitology and Mycology, Arak University of Medical Sciences, Arak, Iran
  3. 3. Student Research Committee, Iran University of Medical Sciences, Tehran, Iran
  4. 4. ENT and Head and Neck Research Center and Department, The Five Senses Health Institute, Firoozgar Hospital, Iran University of Medical Sciences, Tehran, Iran
  5. 5. Department of Infectious Disease, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  6. 6. Department of Microbiology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Source: Mycoses Published:2020


Abstract

Background: Patients with diabetes are known as an important high-risk group for cerebral mucormycosis (CM). Method: We conducted a structured search using PubMed/MEDLINE to collect both case reports and case series case (ie including at least two patients) onto CM in diabetic patient published between 2000 and March 2020. Results: Forty-five reports of individual cases and eighteen case series articles were included. India accounted for the largest share of reports with 37.7% and 38.8% of individual cases and case series, respectively. Mortality ranged from 0% to 100% in the case series. The overall mortality in the individual cases was 46.3%, and 64.2% of deaths were reported in patients with ketoacidosis diabetes. Facial swelling (53.3%), headache (44.4%), loss of vision (35.5%) and ophthalmoplegia (35.5%) were the most frequently reported clinical symptoms. In all patients except 4 (91.1%), CM was treated surgically; however, in many cases (42%), despite the use of surgery, death occurred. Amphotericin B deoxycholate (AMB) and lipid-based AMB (LAMB) were used as the first lines of treatment for all patients; however, posaconazole, echinocandins, hyperbaric oxygen therapy (HBOT) and deferasirox were used in combination for a number of patients. Posaconazole has been shown to have positive therapeutic effect; however, posaconazole, LAMB and HBOT are not commonly used in low-income and health-challenged countries. Conclusion: Cerebral mucormycosis is a rapidly progressive infection in diabetic patients and carries immense morbidity despite early diagnosis and treatment. Low-income countries have had the highest number of reports of the disease in recent years, indicating the need to control diabetes in these countries. © 2020 Wiley-VCH GmbH
Related Docs
View other Related Docs
1. Practice Guideline on Prevention, Diagnosis, and Treatment of Rhino-Orbito-Cerebral Mucormycosis in the Covid-19 Area: A Consensus of Iranian Experts, Archives of Clinical Infectious Diseases (2022)
2. Skull Base Osteomyelitis: A Case Report of Garcin Syndrome Due to Mucormycosis in Covid Pandemic, IDCases (2023)
3. Molecular Identification of Causative Agents in 25 Cases With Mucormycosis in Iran, Archives of Clinical Infectious Diseases (2019)
4. Emerging Challenges in Diagnosis and Treatment of Invasive Fungal Infections: Addressing the Impact of Covid-19 and New Pathogens, Current Fungal Infection Reports (2023)
5. Mucormycosis Infection in Patients With Covid-19: A Systematic Review, Health Science Reports (2022)
6. Challenges and Pitfalls in the Management of Rhino-Orbital Mucormycosis in Ophthalmology: A Highlighted Problem in the Covid-19 Era, Journal of Ophthalmic and Vision Research (2022)
7. Covid-19 Associated Mucormycosis (Cam) in Kashan, Iran: Clinical Presentations, Risk Factors, Management, and Outcomes, Infectious Diseases (2024)
8. Covid-19 Associated Rhino-Orbital-Cerebral Mucormycosis: Clinical Features, Antifungal Susceptibility, Management and Outcome in a Tertiary Hospital in Iran, Mycopathologia (2023)
Experts (# of related papers)
View all Related Experts
Mohammadreza Salehi (9)
Sadegh Khodavaisy (8)
Other Related Docs
9. Subglottic Mucormycosis in a Covid-19 Patient: A Rare Case Report, Oxford Medical Case Reports (2022)
10. A Case of Covid-19-Associated Rhino-Orbito-Cerebral Mucormycosis Caused by Apophysomyces Variabilis With a Review of the Literature, Frontiers in Cellular and Infection Microbiology (2022)
11. Rhinocerebral Mucormycosis in Immunocompetent Patients: A Case Report and Review of Literature, Infection (2024)
12. Covid-19 Associated Mucormycosis Surge: A Review on Multi-Pathway Mechanisms, Parasite Immunology (2024)
13. Case Report: Covid-19-Associated Mucormycosis Co-Infection With Lomentospora Prolificans: The First Case and Review on Multiple Fungal Co-Infections During Covid-19 Pandemic, Frontiers in Medicine (2023)
14. Unusual Orbital Mucormycosis Due to Pecking Injury: Clinical Characteristics and Outcomes of Four Immunocompetent Pediatric Patients, Orbit (London) (2023)
15. Covid-19-Associated Fungal Infections in Iran: A Systematic Review, PLoS ONE (2022)
16. Mucormycosis Infection in Severe Covid-19 Patient With Multiple Underlying Health Conditions, Clinical Case Reports (2021)
17. Relapse of Covid-19-Associated Mucormycosis in Patients Receiving Posaconazole As Maintenance Treatment, Journal of Infection in Developing Countries (2024)
18. Mucormycosis in Patients With Covid-19: A Cross-Sectional Descriptive Multicentre Study From Iran, Mycoses (2021)
19. Covid-19 Associated Rhino-Orbito-Cerebral Mucormycosis, Risk Factors and Outcome Predictors; a Multicentric Study, International Ophthalmology (2023)
20. Distinguishing Characteristics of Covid-19-Associated Mucormycosis; a Case Series, Archives of Academic Emergency Medicine (2022)
21. Molecular Assays Versus Mycological Methods for Diagnosis of Rhino Orbital Mucormycosis: Analysis of 120 Clinical Specimens From Covid-19 Patients, Mycopathologia (2025)
22. The Epidemiological, Clinical, Mycological, and Pathological Features of Rhino-Cerebral Mucormycosis: A Systematic Review, Iranian Journal of Pathology (2022)
23. Ear and Face Mucormycosis; a Case Report, International Tinnitus Journal (2021)
24. The Double-Edged Sword of Systemic Corticosteroid Therapy in Viral Pneumonia: A Case Report and Comparative Review of Influenza-Associated Mucormycosis Versus Covid-19 Associated Mucormycosis, Mycoses (2021)
25. Serious Health Threat of Mucormycosis During the Ongoing Covid-19 Pandemic: What Dermatologists Need to Know in This Regard, International Journal of Dermatology (2022)
26. Covid‑19‑Associated Mucormycosis: A Review of an Emergent Epidemic Fungal Infection in the Era of Covid‑19 Pandemic, Journal of Research in Medical Sciences (2022)